in clinical trials amoxicillin/clavulanic acid is clinically and bacteriologically superior to amoxicillin alone and at least as effective as numerous other comparative agents , such as orally administered cephalosporins , cotrimoxazole , doxycycline and bacampicillin , in the treatment of adults and children with the most common forms of infection encountered in general practice , i.e . urinary tract infections , upper and lower respiratory tract infections , otorhinolaryngological infections , and skin and soft tissue infections .
C0009450
infection
C0149778
soft tissue infections